At CIMS

TACOS 2026 – Dedicated Thoracic and Colorectal Oncology Summit by Marengo CIMS Hospital

cims

Feb 17, 2026 - 12:00

0 3

TACOS 2026 – Dedicated Thoracic and Colorectal Oncology Summit by Marengo CIMS Hospital

Distinguished Faculty Shaping the Scientific Discourse on 21^st & 22^nd Feb 2026

1. Dr. Avanish Saklani – Director, Surgical Oncology, Fortis Hospital, Mumbai, will be speaking on “Role of Robotics and Its Clinical Outcomes in Minimally Invasive Colorectal Surgery” under the session Colon Cancer – Precision Surgery and Adjuvant Care on 22 February 2026 at Hyatt Ahmedabad. A pioneer in advanced colorectal surgery, Dr. Saklani brings extensive expertise in robotic-assisted oncologic procedures and outcome-driven surgical strategies.

2. Dr. Mufaddal Kazi – Professor, Surgical Oncology, TATA Memorial Centre, Mumbai, will deliver his expert perspective during the session Rectal Cancer – Evolving Paradigms and Changing Goals, focusing on “Watch and Wait Strategy: Science or Selective Courage?” on 22 February 2026. Renowned for his academic depth and clinical precision, he will explore contemporary decision-making in rectal cancer care.

3. Prof. K. Chandramohan – Professor & HOD, Surgical Oncology, Sree Mookambika Institute of Medical Sciences, Tamil Nadu, will moderate the panel discussion under Colon Cancer – Precision Surgery and Adjuvant Care, addressing “Key Questions: Are We Over-Treating Early Colon Cancer?” on 22 February 2026. His leadership in multidisciplinary oncology strengthens this evidence-based deliberation.

4. Dr. Manish Bhandare – Professor and Head, HPB and Upper GI Unit, TATA Memorial Centre, Mumbai, will speak in the session Metastatic, Recurrent & Advanced CRC on “Liver Metastases: Resectability Is a Moving Target” on 22 February 2026. A leading authority in hepatobiliary oncology, he will discuss evolving surgical boundaries in metastatic colorectal cancer.

5. Dr. Sandeep Goyle – Head, Medical Oncology, Kokilaben Dhirubhai Ambani Hospital, Mumbai, will present on “Targeted Therapy & Immunotherapy in CRC” during the session Metastatic, Recurrent & Advanced CRC on 22 February 2026. A key voice in precision oncology, he will outline the expanding role of molecularly guided therapies in advanced CRC.

6. Dr. Arvind Krishnamurthy – Professor, Surgical Oncology, Adyar Cancer Institute, Chennai, will speak in the Esophagus Sessions on 21 February 2026, addressing “Recent Advances in Gastro-Esophageal Junction Cancers (Neoadjuvant Treatment and Surgical Strategy).” His expertise in upper GI oncology will bring valuable insights into evolving multimodality treatment approaches.